If you are interested in investing in AstraZeneca shares, in this guide you will find information about this well-known pharmaceutical company as well as a list of AstraZeneca stock brokers regulated by official international bodies.
- AstraZeneca stock brokers
- Getting to know AstraZeneca
- AstraZeneca’s stock market data
- Is now a good time to buy AstraZeneca shares?
- How to invest in AstraZeneca shares?
AstraZeneca stock brokers
Getting to know AstraZeneca
When you think of companies in a sector that is currently on the rise, it is likely that even the least experienced trader will think of pharmaceutical companies. Pfizer, Moderna and AstraZeneca are three names that have gone from being unknown to the average person to appearing in every conversation, be it health or financial, because in bad times there are also opportunities and investing in AstraZeneca shares can be one of them.
OkBrokers has already written about the other two pharmaceutical giants. This time it is the turn of AstraZeneca, which was born in 1999 from the union between the British company Zeneca and the Swedish company Astra. It currently operates in more than 100 countries, although its main strategic activity is carried out in three centres: Cambridge (UK), Gaithersburg (USA) and Gothenburg (Sweden).
They are active in several areas: cardiovascular and metabolic diseases (accounting for 35.3 % of their turnover – the largest), respiratory (20.7 %), oncological, infectious and neurological diseases.
In Spain, AstraZeneca has a team of more than 700 people. Its headquarters are in Madrid. In addition, they have a Centre for Respiratory Medicine in Barcelona (opened in 2015). There are 75 R&D professionals specialised in the development of clinical research on inhaled medicines.
This is a very sketchy overall picture of what this company is all about. But, things being what they are, if it were not for the infamous Covid-19, it is likely that many of you would never have heard this name. If you are considering investing in AstraZecena shares, it is probably because it is one of the drug companies whose vaccine will help (or so it is hoped) to end the coronavirus nightmare.
AstraZeneca’s stock market data
At the time of writing, AstraZeneca shares (listed on the London and New York stock exchanges) are at $7,475, according to en.investing.com. This is higher than in March 2020 (when restrictions began to be applied globally due to the crisis), but significantly lower than the prices they reached during some months of 2020.
Specifically, the company’s shares were trading at $7,216 in March and reached $10,120 in July. So, while in good overall momentum, the company’s assets are not getting the boost one might expect at the moment, given, for example, that supply of the Oxford/AstraZeneca vaccine has already begun in the UK.
Currently, this pharmaceutical company has 1,312,668,724 shares outstanding and its market capitalisation is 98.12 billion dollars. This is higher than that of Moderna ($43.98 billion) and well below that of Pfizer ($208 billion).
AstraZeneca’s shareholding – like that of Pfizer or Moderna – includes the investment fund BlackRock Inc, as well as, among others, Investor or The Capital Group Company. A large part of its shareholding is of floating origin and therefore made up of independent investors.
The big question. The difficult answer. It has already been seen that, despite the fact that its vaccines are already starting to be applied, the shares of this company have not, for the moment, experienced any strong rise. It is also true that they have remained very stable, and not only at the moment, but this is a common trend for this company.
If all goes well, and there are no negative surprises with the vaccine, the company’s assets may grow, either markedly or with a sustained increase of the kind seen in recent times. However, one small mistake, one unexpected side effect, could be a real debacle.
So the answer would be (as with Pfizer or Moderna) that it is a good time to invest in AstraZeneca shares. But that is a statement with a million inverted commas. Remember that before you invest you need to carefully analyse the financial assets you wish to trade and be aware of the risk of capital loss inherent in trading.
When it comes to investing in companies you can find brokers that allow you to buy AstraZeneca shares and others that allow you to trade CFDs or contracts for difference on AstraZeneca shares. Each of these options has both advantages and disadvantages.
If you decide to invest in AstraZeneca through Contracts for Difference (CFDs), you have the opportunity to profit from both the rise and fall in the value of the shares. You play on the difference between the bid and ask price. However, we must warn our readers of the risk of capital loss that CFDs entail, especially if you make use of leverage.
Regulatory bodies such as the CNMV require stock CFD brokers to warn their clients of these risks. In fact, no one should invest in AstraZeneca stock CFDs without having the necessary knowledge to do so. It is also important to adhere to one rule: never invest more than you can afford to lose.
If you decide to buy AstraZeneca shares, it is best to do so through a qualified and regulated online broker. In our listings you will only find brokers licensed by financial institutions. Check the characteristics of each one and choose the one that suits you best. If you decide on the pharmaceutical sector, you not only have to choose a stock broker, but you will also have to study in depth whether you prefer Pfizer, Moderna or AstraZeneca, which are the three main participants in the coronavirus vaccine race.
- Buy Amazon shares
- Buy Banco Santander shares
- Buy Google shares
- Buy Inditex shares
- Buy shares in Moderna
- Buy Pfizer shares
- How to buy shares